Nutritional Supplements and Foot Surgery

NutraHeal46 enrolled

Overview

This is a prospective randomized trial wherein participants will be assigned to NutraHeal™, NutraHeal Plus™, or standard of care for 1 week prior to foot surgery and 3 weeks after surgery. The central hypothesis is that among patients undergoing surgery, nutritional supplements that maintain energy production, muscle structure, immune function, and response to pain will support recovery from surgery.

Over a 6 month period the investigators will enroll 45 male and female patients undergoing foot surgery. This is a prospective randomized trial and participants will be assigned to NutraHeal™ (n=15), NutraHeal Plus™ (n=15), or standard of care (n=15) for 1 week prior to surgery and 3 weeks after surgery. NutraHeal™ is a nutritional supplement that contains 7.5 micrograms (300 IU) of Vitamin D3, 80 mg of Calcium as Calcium Hydroxymethylbutyrate Monohydrate, 7.5 mg of Zinc, 600 mg of Calcium Hydroxymethylbutyrate Monohydrate, and 45 mg of Bromelain. NutraHeal Plus™ is a nutritional supplement that contains 80 mg of Calcium as Calcium Hydroxymethylbutyrate Monohydrate, 7.5 mg of Zinc, 600 mg of Calcium Hydroxymethylbutyrate Monohydrate, 45 mg of Bromelain, and 7.5 mg of reduced Nicotinamide Adenine Dinucleotide (NADH). Patients randomized to standard of care will not receive any of the ingredients in NutraHeal™ or NutraHeal Plus™. The foot surgeon will evaluate the patient for wound healing time, healing quality, erythema and new tissue quality, using a Likert rating scale against expected results from -4 (much worse) to +4 (much better) including the expected reference grade of zero (0). Wound healing will be assessed at 1 and 3 weeks after surgery. Patients will document medication compliance (day of surgery, 1 and 3 weeks after surgery), pain medication use (baseline, on the day of surgery and at 1 and 3 weeks after surgery) and rate overall satisfaction (5-point scale (1 = excellent; 2 = good; 3 = moderate; 4 = sufficient; 5 = unsatisfactory) at 3 weeks after surgery). Patients will also complete the PROMIS-29 instrument at baseline, the day of surgery, and at 1 and 3 weeks after surgery).

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

SUPPORTIVE_CARE

Masking

NONE

Enrollment

Conditions

Foot Injuries and Disorders

Interventions

NutraHealDIETARY_SUPPLEMENT

Receive NutraHeal (2 capsules twice a day) as a dietary supplement beginning 1 week prior to surgery and extending to 3 weeks after foot surgery.

NutraHeal PlusDIETARY_SUPPLEMENT

Receive NutraHeal Plus (2 capsules twice a day) as a dietary supplement beginning 1 week prior to surgery and extending to 3 weeks after foot surgery.

Eligibility

Sex: ALLMin age: 20 YearsMax age: 80 Years

Medical Language ↔ Plain English

Inclusion Criteria: * ≥ 20 years of age * Undergoing foot surgery (matrixectomy (ingrown toenail removal) and wart removal) Exclusion Criteria: * \> 80 years of age * Pregnant patients or those anticipating pregnancy in the 1 month study period * Allergic to pineapple * Treated with oral anticoagulation * Currently receiving Bromelain, Hydroxymethylbutyrate Monohydrate (HMB), reduced Nicotinamide Adenine Dinucleotide (NADH), Vitamin D3, or Zinc. * Alcoholism (\>2 drinks/day) * Insulin Dependent Diabetes * Hepatic insufficiency (prior known liver function tests \> 1.5 times the upper limit of normal) * Renal failure (prior known creatinine \> 2.0 mg/dl) * Severe pulmonary disease (requiring home oxygen therapy) * Psychiatric illness requiring therapy (DSM-V thought disorders, recurrent major depressive disorder)

Locations (3)

Advanced Regional Center for Ankle and Foot Care

Altoona, Pennsylvania, United States

Advanced Regional Center for Ankle & Foot Care

Ebensburg, Pennsylvania, United States

Advanced Regional Center for Ankle & Foot Care

State College, Pennsylvania, United States

Outcomes

Primary Outcomes

Wound Healing at 3 weeks after surgery

Wound healing (time, healing quality, erythema and new tissue quality), using a Likert rating scale against expected results from -4 (much worse) to +4 (much better) including the expected reference grade of zero (0). Positive scores are a better outcome.

Time frame: 3 weeks after surgery.

Secondary Outcomes

Pain Intensity

Average pain intensity over previous 7 days as recorded in PROMIS-29. Pain intensity is graded on a visual analog scale from 0 (no pain) to 10 (worst imaginable pain). Higher scores mean a worse outcome.

Time frame: Baseline, the day of surgery, and at 1 and 3 weeks after surgery.

Pain Interference

Average pain interference over previous 7 days as recorded in PROMIS-29. Pain interference is graded on a scale of 1-5 (1 = Not at all, 2 = A little bit, 3 = Somewhat, 4 = Quite a bit, 5 = Very much). Higher scores mean a worse outcome.

Time frame: Baseline, the day of surgery, and at 1 and 3 weeks after surgery.

Fatigue

Fatigue over previous 7 days as recorded in PROMIS-29. Fatigue is graded on a scale of 1-5 (1 = Not at all, 2 = A little bit, 3 = Somewhat, 4 = Quite a bit, 5 = Very much). Higher scores mean a worse outcome.

Time frame: Baseline, the day of surgery, and at 1 and 3 weeks after surgery.

Wound Healing at 1 week after surgery

Time frame: 1 week after surgery

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.